Methods
We studied patients with HCC from March 2020 to August 2022 and analyzed
their risk factors, clinical characteristics, and treatment modalities.
Patients with at least one clinical, radiological, or biochemical
evidence of HCC were considered for the study. Data were collected using
predetermined proformas.